Welcome to our dedicated page for ADBT news (Ticker: ADBT), a resource for investors and traders seeking the latest updates and insights on ADBT stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ADBT's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ADBT's position in the market.
Advasa Holdings (Nasdaq: ADBT), a fintech payment holding company focused on Earned Wage Access and financial infrastructure via its Japanese subsidiary, announced that its Form S-1 registration statement for a proposed public direct listing was declared effective by the SEC on August 11, 2026.
The company’s common stock has been approved for listing on the Nasdaq Global Market and is expected to begin trading under the ticker symbol “ADBT” on or about August 18, 2026. WestPark Capital acts as financial advisor and Anthony, Linder & Cacomanolis, PLLC as securities counsel. Trading access in Japan is expected through Monex, Rakuten Securities, SBI SECURITIES and Webull Securities (Japan), subject to individual brokerage conditions.